FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285392621> ?p ?o ?g. }

• W4285392621 endingPage "2047" @default.
• W4285392621 startingPage "2034" @default.
• W4285392621 abstract "Adipose tissue is a key regulator of whole-body metabolic fitness because of its role in controlling insulin sensitivity. Obesity is associated with hypertrophic adipocytes with impaired glucose absorption, a phenomenon existing in the ultrarare monogenic disorder Alström syndrome consisting of severe insulin resistance. Inactivation of ALMS1 directly inhibits insulin-mediated glucose absorption in the white adipose tissue and induces severe insulin resistance, which leads to type 2 diabetes, accelerated nonalcoholic liver disease, and fibrosis. These phenotypes were reversed by specific adipocyte-ALMS1 reactivation in vivo. Subsequently, ALMS1 was found to bind to protein kinase C-α (PKCα) in the adipocyte, and upon insulin signaling, PKCα is released from ALMS1. α-Helices in the kinase domain of PKCα were therefore screened to identify a peptide sequence that interfered with the ALMS1-PKCα protein interaction. When incubated with cultured human adipocytes, the stapled peptide termed PATAS, for Peptide derived of PKC Alpha Targeting AlmS, triggered insulin-independent glucose absorption, de novo lipogenesis, and cellular glucose utilization. In vivo, PATAS reduced whole-body insulin resistance, and improved glucose intolerance, fasting glucose, liver steatosis, and fibrosis in rodents. Thus, PATAS represents a novel first-in-class peptide that targets the adipocyte to ameliorate insulin resistance and its associated comorbidities." @default.
• W4285392621 created "2022-07-14" @default.
• W4285392621 creator A5000436427 @default.
• W4285392621 creator A5001845626 @default.
• W4285392621 creator A5003784655 @default.
• W4285392621 creator A5004803054 @default.
• W4285392621 creator A5019887736 @default.
• W4285392621 creator A5024272897 @default.
• W4285392621 creator A5051571051 @default.
• W4285392621 creator A5089366249 @default.
• W4285392621 date "2022-07-13" @default.
• W4285392621 modified "2023-09-30" @default.
• W4285392621 title "PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo" @default.
• W4285392621 cites W1482032523 @default.
• W4285392621 cites W1773423156 @default.
• W4285392621 cites W1954270231 @default.
• W4285392621 cites W1983704964 @default.
• W4285392621 cites W1985592156 @default.
• W4285392621 cites W1985870045 @default.
• W4285392621 cites W1989020172 @default.
• W4285392621 cites W1997036486 @default.
• W4285392621 cites W2009172922 @default.
• W4285392621 cites W2014650116 @default.
• W4285392621 cites W2022419155 @default.
• W4285392621 cites W2042727393 @default.
• W4285392621 cites W2051218026 @default.
• W4285392621 cites W2056408336 @default.
• W4285392621 cites W2057646913 @default.
• W4285392621 cites W2062244719 @default.
• W4285392621 cites W2090784323 @default.
• W4285392621 cites W2112286600 @default.
• W4285392621 cites W2124781995 @default.
• W4285392621 cites W2128305982 @default.
• W4285392621 cites W2142361468 @default.
• W4285392621 cites W2152560090 @default.
• W4285392621 cites W2170864435 @default.
• W4285392621 cites W2509008602 @default.
• W4285392621 cites W2531829478 @default.
• W4285392621 cites W2749250915 @default.
• W4285392621 cites W2759997926 @default.
• W4285392621 cites W2799588847 @default.
• W4285392621 cites W2892416438 @default.
• W4285392621 cites W2904735514 @default.
• W4285392621 cites W2933665664 @default.
• W4285392621 cites W2948851550 @default.
• W4285392621 cites W2954922445 @default.
• W4285392621 cites W2990362342 @default.
• W4285392621 cites W3045678530 @default.
• W4285392621 cites W3087712200 @default.
• W4285392621 cites W3090223792 @default.
• W4285392621 cites W3123533113 @default.
• W4285392621 cites W3178919928 @default.
• W4285392621 cites W835122851 @default.
• W4285392621 doi "https://doi.org/10.2337/db22-0058" @default.
• W4285392621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35822820" @default.
• W4285392621 hasPublicationYear "2022" @default.
• W4285392621 type Work @default.
• W4285392621 citedByCount "1" @default.
• W4285392621 countsByYear W42853926212023 @default.
• W4285392621 crossrefType "journal-article" @default.
• W4285392621 hasAuthorship W4285392621A5000436427 @default.
• W4285392621 hasAuthorship W4285392621A5001845626 @default.
• W4285392621 hasAuthorship W4285392621A5003784655 @default.
• W4285392621 hasAuthorship W4285392621A5004803054 @default.
• W4285392621 hasAuthorship W4285392621A5019887736 @default.
• W4285392621 hasAuthorship W4285392621A5024272897 @default.
• W4285392621 hasAuthorship W4285392621A5051571051 @default.
• W4285392621 hasAuthorship W4285392621A5089366249 @default.
• W4285392621 hasBestOaLocation W42853926211 @default.
• W4285392621 hasConcept C126322002 @default.
• W4285392621 hasConcept C134018914 @default.
• W4285392621 hasConcept C151955695 @default.
• W4285392621 hasConcept C171089720 @default.
• W4285392621 hasConcept C2776175234 @default.
• W4285392621 hasConcept C2776954865 @default.
• W4285392621 hasConcept C2777180221 @default.
• W4285392621 hasConcept C2777391703 @default.
• W4285392621 hasConcept C2777866211 @default.
• W4285392621 hasConcept C2778772119 @default.
• W4285392621 hasConcept C2779134260 @default.
• W4285392621 hasConcept C2779306644 @default.
• W4285392621 hasConcept C555293320 @default.
• W4285392621 hasConcept C71924100 @default.
• W4285392621 hasConcept C86803240 @default.
• W4285392621 hasConceptScore W4285392621C126322002 @default.
• W4285392621 hasConceptScore W4285392621C134018914 @default.
• W4285392621 hasConceptScore W4285392621C151955695 @default.
• W4285392621 hasConceptScore W4285392621C171089720 @default.
• W4285392621 hasConceptScore W4285392621C2776175234 @default.
• W4285392621 hasConceptScore W4285392621C2776954865 @default.
• W4285392621 hasConceptScore W4285392621C2777180221 @default.
• W4285392621 hasConceptScore W4285392621C2777391703 @default.
• W4285392621 hasConceptScore W4285392621C2777866211 @default.
• W4285392621 hasConceptScore W4285392621C2778772119 @default.
• W4285392621 hasConceptScore W4285392621C2779134260 @default.
• W4285392621 hasConceptScore W4285392621C2779306644 @default.
• W4285392621 hasConceptScore W4285392621C555293320 @default.
• W4285392621 hasConceptScore W4285392621C71924100 @default.

• next